Singclean Medical was established in 2002, and has 20 years of expertise in the industry of absorbable biomaterial with over 400 employees. The production base covers an area of 28,000 m2, with 8 GMP purification workshops of 2,000 m2, a logistics center of 4,000 m2, and a R&D center and a quality inspection center of 1,000 m2. Singclean has an annual production capacity of 12 million sets of various medical devices, and achieved sales over 90 million euros in 2021.

Singclean has a strong research and development team with more than 40 experienced engineers. Each year, over 9 million euros is invested into R&D to create pioneering medical products, like tissue engineering products.

There are currently 8 series of products (medical sodium hyaluronate gel products, chitosan products, cross-linked sodium hyaluronate gel products, microporous polysaccharide products, oxidized regenerated cellulose products, in vitro diagnostic reagent products, collagen sponge, regenerative medicine engineering basic material products) with 50 varieties are exported to 120 countries around the world, like: Italy, Germany, Turkey, Brazil, Chile.

Singclean has obtained 30 CE certificates, 2 FDA Certificates, 17 medical device registration certificates and 46 patent certificates, including 3 international patent certificates.

Singclean is committed to improving the health and quality of life of people around the world through our innovative products and services.